Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.

Saved in:
Bibliographic Details
Title: Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.
Authors: Akat ΕO; Division of Rheumatology, Manisa State Hospital, Manisa, Türkiye; Rheumatology and Clinical Immunology Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Kostopoulou M; Department of Nephrology, 'G. Gennimatas' General Hospital, Athens, Greece., Katechis S; Rheumatology and Clinical Immunology Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Drougkas K; Rheumatology and Clinical Immunology Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Chavatza K; Rheumatology and Clinical Immunology Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Kronbichler A; Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria., Pons-Estel BA; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Grupo Oroño, Rosario, Argentina., Rovin BH; Wexner Medical Center, Ohio State University, Columbus, OH, USA., Nagy G; Department of Rheumatology and Immunology, Heart and Vascular Center, Semmelweis University, Budapest, Hungary; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary., Yazdany J; Division of Rheumatology, University of California San Francisco, San Francisco, CA, USA., Carter LM; NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK., Quintana LF; National Reference Centre on Complex Glomerular Disease (CSUR), Nephrology Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Nikpour M; Department of Rheumatology, The University of Melbourne and St. Vincent's Hospital, Melbourne, VIC, Australia; Department of Rheumatology, The University of Sydney and Royal Prince Alfred Hospital, Sydney, NSW, Australia., Praga M; Department of Medicine, Complutense University, Madrid, Spain., Ugarte-Gil MF; Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru; Rheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru., Dall'Era M; Division of Rheumatology, University of California San Francisco, San Francisco, CA, USA., Trachana M; Pediatric Immunology and Rheumatology Referral Centre, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Mosca M; Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Ward MM; Verier Outcomes Research, Rockville, MD, USA., Zhao MH; Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China., Inanc M; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Türkiye., Yajima N; Division of Rheumatology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Navarra S; Section of Rheumatology, University of Santo Tomas Hospital, Manila, Philippines., Lionaki S; Division of Nephrology, Department of Medicine, National and Kapodistrian University of Athens, School of Health Sciences, Attikon General Hospital, Athens, Greece., Gheita TA; Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt., Tesar V; General University Hospital, Charles University, Prague, Czech Republic., Amoura Z; French National Reference Center for SLE, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France., Touma Z; University of Toronto Lupus Clinic, Division of Rheumatology, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada., Bertsias G; Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece., Fanouriakis A; Rheumatology and Clinical Immunology Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Boumpas DT; Rheumatology and Clinical Immunology Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece; Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Joint Academic Rheumatology Program, National and Kapodistrian University of Athens Medical School, Athens, Greece. Electronic address: boumpasd@uoc.gr.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 Jul 10. Date of Electronic Publication: 2026 Jul 10.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2026.05.030